Name | 3,4-Bis(4-hydroxyphenyl)-7-chromanol |
---|---|
Synonyms |
3-(4-hydroxy-phenyl)-2-phenyl-thiazolidin-4-one
3-(4-hydroxyphenyl)-4-(4-hydroxyphenyl)chroman-7-ol 4-Thiazolidinone,3-(4-hydroxyphenyl)-2-phenyl |
Description | ME-143 is a second-generation tumor-specific inhibitor of NADH oxidase. ME-143 inhibits the WNT/β-catenin pathway in colorectal cancer cells. ME-143 has broadly active against cancers in vitro and in vivo[1]. |
---|---|
Related Catalog | |
Target |
NADH oxidase[1] |
In Vitro | ME-143 (0-100 μM; 48 hours) reduces proliferation of DLD1 cell line by approximately 40% at a concentration of 3.125 μM, and is more potent than Genistein[1]. Cell Proliferation Assay[1] Cell Line: RKO cell; DLD1 cell Concentration: 0-100 μM Incubation Time: 48 hours Result: Reduced proliferation of DLD1 cell line by approximately 40% at a concentration of 3.125 μM, and was more potent than Genistein. |
In Vivo | NADH氧化酶抑制剂 |
References |
Molecular Formula | C21H18O4 |
---|---|
Molecular Weight | 334.36500 |
Exact Mass | 334.12100 |
PSA | 69.92000 |
LogP | 4.11150 |
~% 852536-39-1 |
Literature: MARSHALL EDWARDS, INC.; JEOFFREYS, George; JOHNSON, Alison; MORENO, Ofir Patent: WO2012/61409 A1, 2012 ; Location in patent: Page/Page column 36; 37 ; |
~% 852536-39-1 |
Literature: MARSHALL EDWARDS, INC.; JEOFFREYS, George; JOHNSON, Alison; MORENO, Ofir Patent: WO2012/61409 A1, 2012 ; |
~% 852536-39-1 |
Literature: MARSHALL EDWARDS, INC.; JEOFFREYS, George; JOHNSON, Alison; MORENO, Ofir Patent: WO2012/61409 A1, 2012 ; |
~% 852536-39-1 |
Literature: MARSHALL EDWARDS, INC.; JEOFFREYS, George; JOHNSON, Alison; MORENO, Ofir Patent: WO2012/61409 A1, 2012 ; |
~% 852536-39-1 |
Literature: MARSHALL EDWARDS, INC.; JEOFFREYS, George; JOHNSON, Alison; MORENO, Ofir Patent: WO2012/61409 A1, 2012 ; |
~% 852536-39-1 |
Literature: MARSHALL EDWARDS, INC.; JEOFFREYS, George; JOHNSON, Alison; MORENO, Ofir Patent: WO2012/61409 A1, 2012 ; |
Precursor 6 | |
---|---|
DownStream 0 |